Meenal Sethna

October 5, 2026

SPXC receives analyst coverage and growth focus. Recent analyst notes emphasize SPX Technologies' growth profile, citing its market position and revenue trends. Oppenheimer kept an Outperform rating but adjusted its price target to $270, reflecting a more modest outlook. A separate piece highlighted the compound return of a $100 investment over 15 years, underscoring the stock’s long‑term performance while it trades near the lower end of its 52‑week range.

October 11, 2026

McKesson moves to acquire Option Care Health in $5.8B deal. Option Care Health is the target of a $5.8 billion acquisition by McKesson, which has lifted the stock in recent trading. The deal is under legal review, and several analysts have lowered their ratings, with UBS moving to neutral and William Blair to market‑perform. The mixed reactions reflect both the premium offered and the uncertainties around regulatory approval.

October 4, 2026

Littelfuse (LFUS) Cited for Trend Momentum. A recent analysis highlights Littelfuse for meeting specific trend template criteria, citing high-growth momentum and a breakout setup. This technical perspective aligns with the stock's current position near its 52-week high of $500.57. The company maintains a modest dividend yield of 1.11%, while analysts hold an average price target of $488.75.